痛みの包括的レビュー:モデル、標的、治療、展望(レビュー)
Chenyu Chang1, Xutao Wu1, Kejia Liu2
1Jiangxi Key Laboratory for Sustainable Utilization of Chinese Material Medical Resources, Key Laboratory of Modern Preparation of Traditional Chinese Medicine of Ministry of Education, The Second Affiliated Hospital, Jiangxi University of Traditional Chinese Medicine, Nanchang, Jiangxi 330004, P.R. China.
International journal of molecular medicine
|December 19, 2025
まとめ
本レビューは、洗練された動物モデルやイオンチャネルなどの分子標的を含む、疼痛研究の進歩を詳述する。将来の疼痛管理は、多角的治療法と個別化戦略を統合するだろう。
科学分野:
- 神経科学
- 薬理学
- 疼痛医学
背景:
- 痛みは、生存に不可欠なメカニズムであるが、世界的な健康上の大きな課題でもある。
- 患者の幸福と社会の発展を改善するためには、痛みのメカニズムを理解することが不可欠である。
研究 の 目的:
- 疼痛管理における研究進歩を体系的にレビューおよび分析する。
- 動物モデル、分子標的、治療アプローチ、および疼痛研究の将来の方向性を網羅する。
主な方法:
- 神経障害性疼痛、癌誘発性疼痛、内臓痛の進化する動物モデルのレビュー。
- 電位依存性イオンチャネル、Gタンパク質共役受容体、炎症関連酵素を含む分子標的の同定。
- 現在の臨床戦略の分析:多角的統合、オピオイド最適化、非オピオイド革新、神経調節、心理的介入。
主要な成果:
- 高度な動物モデルは、臨床的な疼痛状態をより良く模倣する。
- 主要な分子標的は、新規鎮痛薬設計の基盤を提供する。
- 臨床治療はますます多角的になり、薬物療法、神経調節、行動介入を組み合わせています。
結論:
- かなりの進歩があったものの、真に治癒的な疼痛治療は依然として長期的な目標である。
- 将来の研究は、病理学的メカニズム、オピオイドの副作用、個別化医療、学際的協力に焦点を当てるべきである。
関連する概念動画
Analgesia and Pain Management
1.4K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.4K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Pain
1.2K
Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...
1.2K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
872
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
872
Opioid Receptors: Overview
3.8K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.8K
Targets for Drug Action: Overview
9.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.9K


